William D. Foulkes

发表

An ovarian tumor marker with homology to vaccinia virus contains an IgV-like region and multiple transmembrane domains.

W. Foulkes, J. Trowsdale, P. Freemont, 1992, Cancer research.

Functional and phenotypic consequences of an unusual inversion in MSH2.

Christopher D. Heinen, N. Sabbaghian, Abhijit Rath, 2023, Familial cancer.

Genetic and molecular analyses of candidate germline BRIP1/FANCJ variants implicated in breast and ovarian cancer

J. Ragoussis, A. Mes-Masson, D. Provencher, 2023, medRxiv.

Cancer Screening Recommendations and Clinical Management of Inherited Gastrointestinal Cancer Syndromes in Childhood

W. Foulkes, D. Evans, K. Nathanson, 2017, Clinical Cancer Research.

Germline truncating mutations in both MSH2 and BRCA2 in a single kindred

W. Foulkes, F. Odefrey, I. Thiffault, 2004, British Journal of Cancer.

Loss of heterozygosity and amplification on chromosome 11q in human ovarian cancer.

G. W. Stamp, W. Foulkes, G. Stamp, 1993, British Journal of Cancer.

MDM2 overexpression is rare in ovarian carcinoma irrespective of TP53 mutation status.

W. Foulkes, G. Stamp, J. Trowsdale, 1995, British Journal of Cancer.

Clinical and biological landscape of constitutional mismatch-repair deficiency syndrome: an International Replication Repair Deficiency Consortium cohort study.

K. Cole, D. Gass, A. Shlien, 2024, The Lancet. Oncology.

Localization of an ovarian cancer tumor suppressor gene to a 0.5-cM region between D22S284 and CYP2D, on chromosome 22q.

W. Foulkes, I. Campbell, M. Davis, 1996, Cancer research.